oxazoles has been researched along with Infections, Picornaviridae in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.11) | 18.7374 |
| 1990's | 3 (16.67) | 18.2507 |
| 2000's | 8 (44.44) | 29.6817 |
| 2010's | 5 (27.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Blaas, D; Goessweiner-Mohr, N; Kirchmair, J; Makarov, VA; Marlovits, TC; Mathai, N; Pasin, M; Real-Hohn, A; Richter, M; Schmidtke, M; Verdaguer, N; Wald, J; Walther, C; Zanella, I | 1 |
| DeBiasi, RL; Harik, N | 1 |
| Berggren, PO; Blixt, M; Holmberg, R; Juntti-Berggren, L; Klitz, W; Niklasson, B | 1 |
| Baek, SH; Choi, HJ; Kwon, DH; Lim, CH; Song, JH | 1 |
| Harvala, H; Pajkrt, D; Wildenbeest, JG; Wolthers, KC | 1 |
| Boelens, JJ; Douma, JW; Rademaker, C; Sanders, EA; van de Ven, AA; van Loon, AM; van Montfrans, JM; Wensing, AM | 1 |
| Florea, NR; Maglio, D; Nicolau, DP | 1 |
| Coats, TL; Collett, M; Cooper, EC; Hayden, FG; Herrington, DT; Hudson, S; Kim, K; Liu, S; McKinlay, M; Pevear, DC; Villano, SA | 1 |
| Fleischer, R; Laessig, K | 1 |
| Hayden, FG | 1 |
| Diana, GD; McKinlay, MA; Rogers, JM | 1 |
| Le Moing, V | 1 |
| Ballesteros, F; Reina, J | 1 |
| Turner, RB | 1 |
| Billich, A | 1 |
| Blatter, MM; Coats, T; Hassman, HA; Hayden, FG; Kim, K; Liu, S; Zhang, B | 1 |
| Brisson, CJ; Diana, GD; McKinlay, MA; Miralles, JV; Salvador, UJ; Zalay, ES | 1 |
| Akullian, V; Diana, GD; McKinlay, MA; Oglesby, C; Otto, MJ | 1 |
8 review(s) available for oxazoles and Infections, Picornaviridae
| Article | Year |
|---|---|
Neonatal nonpolio enterovirus and parechovirus infections.
Topics: Antiviral Agents; Cross Infection; Enterovirus; Enterovirus Infections; Female; Fomites; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Oxadiazoles; Oxazoles; Parechovirus; Phenyl Ethers; Picornaviridae Infections; Polymerase Chain Reaction; Pregnancy; Pregnancy Complications, Infectious | 2018 |
The need for treatment against human parechoviruses: how, why and when?
Topics: Animals; Antiviral Agents; Central Nervous System Infections; Disease Models, Animal; Humans; Infant, Newborn; Oxadiazoles; Oxazoles; Parechovirus; Picornaviridae Infections; Sepsis | 2010 |
Pleconaril, a novel antipicornaviral agent.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Area Under Curve; Biological Availability; Half-Life; Humans; Middle Aged; Oxadiazoles; Oxazoles; Picornaviridae Infections; Randomized Controlled Trials as Topic | 2003 |
Update on influenza and rhinovirus infections.
Topics: Acetamides; Amines; Antiviral Agents; Common Cold; Guanidines; Humans; Influenza, Human; Intercellular Adhesion Molecule-1; Neuraminidase; Oseltamivir; Oxadiazoles; Oxazoles; Picornaviridae Infections; Pyrans; Recombinant Proteins; Rhinovirus; Sialic Acids; Zanamivir | 1999 |
Pleconaril. A broad spectrum antipicornaviral agent.
Topics: Antiviral Agents; Enterovirus; Humans; Meningitis, Viral; Oxadiazoles; Oxazoles; Picornaviridae Infections | 1999 |
[Pleconaril, a new aniviral drug with activity against picornavirus].
Topics: Animals; Antiviral Agents; Drug Resistance; Humans; Oxadiazoles; Oxazoles; Picornaviridae; Picornaviridae Infections | 2000 |
The treatment of rhinovirus infections: progress and potential.
Topics: 3C Viral Proteases; Antiviral Agents; Clinical Trials as Topic; Combined Modality Therapy; Common Cold; Cysteine Endopeptidases; Dietary Supplements; Drug Therapy, Combination; Echinacea; Enzyme Inhibitors; Histamine H1 Antagonists; Humans; Intercellular Adhesion Molecule-1; Isoxazoles; Oxadiazoles; Oxazoles; Phenylalanine; Phytotherapy; Picornaviridae Infections; Plant Extracts; Plants, Medicinal; Pyrrolidinones; Receptors, Virus; Rhinovirus; Valine; Viral Proteins; Zinc | 2001 |
Pleconaril Sanofi Synthélabo/ViroPharma.
Topics: Antiviral Agents; Clinical Trials as Topic; Contraindications; Drugs, Investigational; Humans; Oxadiazoles; Oxazoles; Picornaviridae; Picornaviridae Infections; Structure-Activity Relationship | 2000 |
2 trial(s) available for oxazoles and Infections, Picornaviridae
| Article | Year |
|---|---|
Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials.
Topics: Administration, Oral; Adult; Antiviral Agents; Common Cold; Diarrhea; Double-Blind Method; Female; Humans; Male; Nausea; Oxadiazoles; Oxazoles; Picornaviridae; Picornaviridae Infections; Prospective Studies; Treatment Outcome | 2003 |
Oral pleconaril treatment of picornavirus-associated viral respiratory illness in adults: efficacy and tolerability in phase II clinical trials.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antiviral Agents; Double-Blind Method; Female; Humans; Male; Middle Aged; Oxadiazoles; Oxazoles; Picornaviridae Infections; Respiratory Tract Infections; Virus Shedding | 2002 |
8 other study(ies) available for oxazoles and Infections, Picornaviridae
| Article | Year |
|---|---|
Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.
Topics: Antiviral Agents; Binding Sites; Capsid; Cryoelectron Microscopy; Drug Resistance, Viral; HeLa Cells; Humans; Models, Molecular; Molecular Structure; Oxadiazoles; Oxazoles; Picornaviridae Infections; Protein Binding; Protein Conformation; Rhinovirus; Structure-Activity Relationship; Viral Proteins | 2019 |
Antiviral treatments reduce severity of diabetes in Ljungan virus-infected CD-1 mice and delay onset in diabetes-prone BB rats.
Topics: Animals; Antibodies, Viral; Antiviral Agents; Diabetes Mellitus, Type 1; Drug Therapy, Combination; Humans; Immunologic Factors; Mice; Oxadiazoles; Oxazoles; Parechovirus; Picornaviridae Infections; Rats; Rats, Inbred BB; Ribavirin | 2009 |
Anti-human rhinovirus activity of raoulic acid from Raoulia australis.
Topics: Antiviral Agents; Asteraceae; Common Cold; Humans; Microbial Sensitivity Tests; Oxadiazoles; Oxazoles; Phytotherapy; Picornaviridae Infections; Plant Extracts; Rhinovirus; Ribavirin; Terpenes; Virus Internalization | 2010 |
Pleconaril-resistant chronic parechovirus-associated enteropathy in agammaglobulinaemia.
Topics: Adolescent; Agammaglobulinemia; Antiviral Agents; Caliciviridae Infections; Chronic Disease; Drug Resistance, Viral; Feces; Humans; Immunocompromised Host; Male; Norovirus; Oxadiazoles; Oxazoles; Parechovirus; Picornaviridae Infections; Protein-Losing Enteropathies | 2011 |
Safety and efficacy evaluation of pleconaril for treatment of the common cold.
Topics: Adult; Antiviral Agents; Common Cold; Controlled Clinical Trials as Topic; Drug Resistance, Viral; Evaluation Studies as Topic; Humans; Oxadiazoles; Oxazoles; Picornaviridae Infections | 2003 |
[New antivirals for respiratory tract viruses].
Topics: Antiviral Agents; Drug Approval; France; Guanidines; Humans; Influenza, Human; Neuraminidase; Oxadiazoles; Oxazoles; Picornaviridae Infections; Pyrans; Respiratory Tract Infections; Sialic Acids; Zanamivir | 1999 |
Isoxazoles with antipicornavirus activity.
Topics: Animals; Antiviral Agents; Isoxazoles; Mice; Mice, Inbred ICR; Oxazoles; Picornaviridae; Picornaviridae Infections; Structure-Activity Relationship | 1985 |
[[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating.
Topics: Animals; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Isoxazoles; Mice; Oxazoles; Picornaviridae Infections; Poliovirus; Rhinovirus; Structure-Activity Relationship; Time Factors; Virus Replication | 1985 |